Cited by 5BRCA gene mutations in cancerGenetic factors in colorectal cancerGenomics and Rare Diseases

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Precision Prevention: The Current State and Future of Genomically Guided Cancer Prevention

Abstract

The identification of cancer-predisposing germline variants has potentially substantial clinical impact for patients and their families. Although management guidelines have been proposed for some genes, guidelines for other genes are lacking. This review focuses on the current surveillance and management guidelines for the most common hereditary cancer syndromes and discusses some of the most pivotal studies supporting the available guidelines. We also highlight the gaps in the identification of germline carriers, the cascade testing of at-risk relatives, and the challenges impeding the proper follow-up and optimal management of pathogenic germline carriers. The anticipated surge in the number of identified germline carriers, deficient management guidelines, poor cascade testing uptake, and long-term follow-up necessitate the development of multidisciplinary clinics as an obligatory step toward the improvement of cancer prevention.

Overview

Integrity signals

Registry

Crossref · 10.1200/po.19.00278

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 122

  1. 10.1093/annonc/mdw018 · DOI
  2. 10.1001/jamaoncol.2015.5208 · DOI
  3. 10.1158/1078-0432.CCR-16-0015 · DOI
  4. 10.1126/scitranslmed.aaa7161 · DOI
  5. 10.3322/caac.21448 · DOI
  6. 10.1200/JCO.18.00283 · DOI
  7. 10.1097/01.AOG.0000267500.27329.85 · DOI
  8. 10.1200/JCO.2009.23.7784 · DOI
  9. 10.1001/jama.296.12.1507 · DOI
  10. 10.1038/nrc3878 · DOI
  11. 10.1097/DCR.000000000000000 · DOI
  12. 10.1038/ajg.2014.435 · DOI · Paper page
  13. 10.1001/jamaoncol.2017.0619 · DOI
  14. 10.1053/j.gastro.2004.03.068 · DOI
  15. 10.1111/codi.12778 · DOI
  16. 10.1007/s00384-013-1745-2 · DOI
  17. 10.1016/S0016-5085(00)70168-5 · DOI · Paper page
  18. 10.1053/j.gastro.2010.02.053 · DOI
  19. 10.1016/j.cgh.2009.10.003 · DOI
  20. 10.1200/JCO.2004.06.128 · DOI
  21. 10.1001/archinte.164.17.1881 · DOI
  22. 10.1111/j.1399-0004.2008.01125.x · DOI
  23. 10.1016/S1470-2045(09)70041-5 · DOI
  24. 10.1111/j.1600-0412.2011.01091.x · DOI
  25. 10.1002/ijc.22446 · DOI
  26. 10.1016/S0090-8258(03)00371-8 · DOI
  27. 10.1002/cncr.10380 · DOI
  28. 10.1200/JCO.2014.58.1322 · DOI
  29. 10.1056/NEJMoa052627 · DOI
  30. 10.1111/j.1399-0004.2012.01929.x · DOI
  31. 10.1016/j.ejca.2015.12.005 · DOI
  32. 10.1055/s-0032-1313780 · DOI
  33. 10.1200/JCO.2012.43.2278 · DOI
  34. Müller A, 2002, Cancer Res, 62, 1014
  35. 10.1086/320610 · DOI
  36. 10.1002/ijc.23508 · DOI
  37. 10.1016/S0140-6736(11)61049-0 · DOI
  38. Nelson HD, Fu R, Goddard K, et al: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Rockville, MD, Agency for Healthcare Research and Quality, 2013 · DOI
  39. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1147>3.0.CO;2-C · DOI
  40. 10.1002/cncr.20989 · DOI
  41. 10.1200/JCO.2013.53.6607 · DOI
  42. 10.1200/JCO.2004.04.188 · DOI · Paper page
  43. 10.1056/NEJM199901143400201 · DOI
  44. 10.1056/NEJMoa031759 · DOI
  45. 10.1200/JCO.2009.27.0835 · DOI
  46. 10.7326/0003-4819-148-9-200805060-00007 · DOI · Paper page
  47. 10.1002/cncr.25971 · DOI
  48. 10.1001/jama.286.18.2251 · DOI
  49. 10.6004/jnccn.2006.0017 · DOI
  50. 10.1056/NEJMed020044 · DOI
  51. 10.1097/01.AOG.0000228959.30577.13 · DOI
  52. 10.1200/JCO.2013.53.2820 · DOI
  53. 10.1056/NEJMoa020119 · DOI
  54. 10.1056/NEJMoa012158 · DOI
  55. 10.1093/jnci/djn442 · DOI · Paper page
  56. 10.1200/JCO.2007.13.9626 · DOI
  57. 10.1016/S0140-6736(15)01224-6 · DOI · Paper page
  58. 10.1016/S1470-2045(09)70026-9 · DOI
  59. 10.1200/JCO.2016.69.9330 · DOI
  60. 10.1158/1078-0432.CCR-15-2750 · DOI
  61. 10.3200/BMED.31.3.93-106 · DOI
  62. 10.1007/s10897-006-9026-7 · DOI
  63. 10.1002/ajmg.a.10102 · DOI
  64. 10.1016/j.ygyno.2013.12.014 · DOI
  65. 10.1006/pmed.2000.0684 · DOI
  66. 10.1007/s10897-016-9981-6 · DOI
  67. 10.1200/JCO.2008.16.6959 · DOI
  68. 10.1001/jamaoncol.2017.2459 · DOI
  69. 10.1002/humu.22559 · DOI
  70. 10.1158/1078-0432.CCR-17-0408 · DOI · Paper page
  71. 10.1038/nrclinonc.2014.41 · DOI
  72. Garber JE, 1991, Cancer Res, 51, 6094
  73. 10.7326/0003-4819-71-4-747 · DOI
  74. Nichols KE, 2001, Cancer Epidemiol Biomarkers Prev, 10, 83
  75. Sidransky D, 1992, Cancer Res, 52, 2984
  76. 10.1002/cncr.30248 · DOI
  77. 10.1007/s10549-012-1993-9 · DOI
  78. 10.1007/s10549-017-4531-y · DOI
  79. 10.1136/jmg.2010.078113 · DOI · Paper page
  80. 10.1002/cncr.26377 · DOI
  81. 10.1001/jamaoncol.2017.1968 · DOI
  82. 10.1016/S1470-2045(16)30249-2 · DOI · Paper page
  83. 10.1016/S1470-2045(11)70119-X · DOI
  84. 10.1086/426403 · DOI
  85. 10.1001/jamaoncol.2017.0424 · DOI
  86. 10.1200/JCO.2007.12.5922 · DOI
  87. 10.1200/JCO.2010.34.0778 · DOI
  88. 10.1086/421251 · DOI
  89. 10.1089/dna.2013.1970 · DOI
  90. 10.7314/APJCP.2012.13.4.1355 · DOI
  91. 10.1016/j.ejca.2011.03.025 · DOI
  92. 10.1001/jamaoncol.2018.6477 · DOI
  93. 10.3747/co.25.3707 · DOI
  94. 10.1093/jnci/94.3.205 · DOI
  95. 10.1186/bcr2919 · DOI
  96. 10.1200/JCO.2015.65.0747 · DOI
  97. 10.1002/gepi.21971 · DOI
  98. 10.1002/humu.20415 · DOI
  99. 10.1038/sj.bjc.6602007 · DOI
  100. 10.1158/1055-9965.EPI-15-0455 · DOI · Paper page
  101. 10.1038/bjc.2014.30 · DOI
  102. 10.1056/NEJMoa1603144 · DOI · Paper page
  103. 10.1016/j.ygyno.2017.08.030 · DOI
  104. 10.1001/jama.2017.11137 · DOI
  105. 10.1038/ejhg.2016.94 · DOI
  106. 10.1016/j.jmoldx.2015.04.001 · DOI
  107. 10.1007/s10689-015-9854-4 · DOI
  108. 10.1097/GIM.0b013e318164540b · DOI
  109. 10.1093/tbm/ibx010 · DOI
  110. 10.1093/jnci/djy147 · DOI
  111. 10.1002/ajmg.c.31599 · DOI
  112. 10.3747/co.21.1579 · DOI
  113. 10.1210/jc.2014-1498 · DOI · Paper page
  114. 10.1038/nrendo.2014.188 · DOI
  115. 10.1001/jamadermatol.2015.4356 · DOI
  116. 10.1111/pcmr.12333 · DOI
  117. 10.1007/s10689-018-0086-2 · DOI
  118. 10.1093/jlb/lsx038 · DOI
  119. Swannell C, 2018, Med J Aust, 209, C1, 10.5694/mja18.n1911 · DOI
  120. Brierley KL, 2010, Conn Med, 74, 413
  121. 10.1200/JCO.2016.71.6480 · DOI
  122. 10.1186/s13053-018-0090-4 · DOI

Cited by

Metadata

Authors
Kassem, N., Stout, L. A., Hunter, C., Schneider, B., & Radovich, M.
Affiliations
Indiana University Health (US)
Venue
JCO Precision Oncology
Published
2020-11
Volume
4
Issue
4
Pages
96-108
ISSN
2473-4284 (ISSN-L)
OpenAlex
W3007504345
Cited by
5
References
7
Citations by year
2026: 1 · 2021: 3 · 2020: 1
FWCI
0.58
Type
journal article
Language
en
Open access
closed
Locations
  • JCO Precision Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
hereditary cancer, germline mutations, cancer susceptibility, cancer surveillance, management guidelines, cascade testing, multidisciplinary clinic, personalized prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review